ArticleResuscitation plus2026
Hypoxic hepatitis after cardiac arrest is associated with 30-day mortality, poor neurological outcome and non-occlusive mesenteric ischemia.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: Abdominal organ dysfunction after cardiac arrest may reflect hepatosplanchnic hypoperfusion. Hypoxic hepatitis may indicate severe systemic hypoperfusion and a hepatosplanchnic ischemic phenotype. We assessed hypoxic hepatitis occurrence and associations with 30-day mortality, favourable neurological outcome and non-occlusive mesenteric ischemia after conventional and extracorporeal cardiopulmonary resuscitation (CPR, ECPR). Methods: We performed a retrospective single-centre cohort study of adult patients admitted after cardiac arrest between 11/2020 and 02/2026. Hypoxic hepatitis was defined as peak aspartate or alanine aminotransferase ≥20 times the sex-specific upper limit of normal within 72 h after collapse, after exclusion of primary non-hypoxic hepatopathy. Analyses were restricted to patients alive at 72 h and performed separately for CPR and ECPR using adjusted Cox proportional hazards and logistic regression models. Results: Among 835 patients, hypoxic hepatitis occurred in 58/702 CPR patients (8.3%) and 29/133 ECPR patients (21.8%). In the CPR cohort, hypoxic hepatitis was associated with higher 30-day mortality (adjusted HR 1.63, 95% CI 1.11-2.42), lower odds of favourable neurological survival (adjusted OR 0.33, 95% CI 0.17-0.64) and higher odds of non-occlusive mesenteric ischemia (adjusted OR 7.02, 95% CI 2.61-18.89). Corresponding adjusted estimates in ECPR patients were HR 2.65 (95% CI 1.44-4.90), OR 0.09 (95% CI 0.02-0.33) and OR 3.99 (95% CI 1.35-11.78), respectively. Conclusion: Among patients alive 72 h after cardiac arrest, hypoxic hepatitis was associated with increased 30-day mortality, poor neurological outcome and non-occlusive mesenteric ischemia and may help identify a hepatosplanchnic high-risk phenotype after both CPR and ECPR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.